Biocurie

BioCurie is developing a scalable AI-driven platform to optimize the manufacturing of cell, gene, and nucleic acid therapies (CGTs). The platform uniquely combines mechanistic modeling with AI to address production challenges such as cost, speed, and quality in CGT manufacturing. This integration allows biopharmaceutical companies to significantly improve speed, quality, affordability, and patient access to lifesaving gene medicines for patients. The flexible modular nature of the platform means that new modalities (viral gene therapy, cell therapy, RNA, DNA, regenerative medicine, etc.) can be added to the platform as new modules, allowing the BioCurie Platform to expand and evolve as new therapeutic modalities are developed, thereby adding new revenue streams.